TCM
WST icon

Twin Capital Management’s West Pharmaceutical WST Stock Holding History

Twin Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,830
Closed -$644K – 298
2023
Q4 		$644K Hold
1,830
– – 0.08% 206
2023
Q3 		$687K Sell
1,830
-154
-8% -$59.6K 0.1% 194
2023
Q2 		$759K Sell
1,984
-18
-0.9% -$6.43K 0.1% 195
2023
Q1 		$694K Sell
2,002
-132
-6% -$38.6K 0.09% 204
2022
Q4 		$502K Sell
2,134
-1,306
-38% -$309K 0.07% 242
2022
Q3 		$847K Sell
3,440
-11,803
-77% -$3.6M 0.11% 193
2022
Q2 		$4.61M Sell
15,243
-211
-1% -$68.7K 0.59% 38
2022
Q1 		$6.35M Sell
15,454
-1,080
-7% -$423K 0.68% 30
2021
Q4 		$7.75M Buy
16,534
+880
+6% +$379K 0.78% 23
2021
Q3 		$6.65M Sell
15,654
-1,850
-11% -$780K 0.68% 28
2021
Q2 		$6.29M Buy
17,504
+8,764
+100% +$2.9M 0.58% 42
2021
Q1 		$2.46M Buy
8,740
+1,340
+18% +$384K 0.25% 129
2020
Q4 		$2.1M Buy
7,400
+1,410
+24% +$396K 0.19% 141
2020
Q3 		$1.65M Buy
+5,990
New +$1.59M 0.15% 166
2018
Q4 		– Sell
-4,005
Closed -$494K – 328
2018
Q3 		$494K Buy
+4,005
New +$449K 0.02% 307

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Twin Capital Management's WST Position: Q1 2024 in Review

Twin Capital Management sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 1,830 shares — an estimated $644K sold.

Twin Capital Management first reported a position in WST in Q3 2018 and held it in 15 quarters. The position peaked at $7.75M in Q4 2021. 779 funds tracked by Wall St. Rank hold WST as of Q1 2024.

  • Twin Capital Management reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
  • Twin Capital Management sold 1,830 West Pharmaceutical shares in Q1 2024, an estimated $644K.
  • Twin Capital Management first reported a position in West Pharmaceutical in Q3 2018 and held it in 15 quarters.
  • Twin Capital Management's West Pharmaceutical position peaked at $7.75M in Q4 2021.
  • 779 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Twin Capital Management's 13F filing for Q1 2024, filed 13 May 2024.